NCT07215091 Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer Survivors
| NCT ID | NCT07215091 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stony Brook University |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 84 participants |
| Start Date | 2025-01-04 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 84 participants in total. It began in 2025-01-04 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to test a brief motivational intervention to increase physical activity in a group of cancer survivors who are participants in the World Trade Center Health Program.
Eligibility Criteria
Inclusion Criteria: * Participation in the World Trade Center Health Program * History of cancer, completed treatment * Ability to be physically active (at minimum be able to walk slowly) Exclusion Criteria: * Participants receiving active cancer treatment (excluding hormonal therapy); * Late-stage cancer (metastatic); * Inability to follow the scheduled visits; * Women who are pregnant * Patients who would not be safe exercising without medical supervision (ECOG score of 3, significant comorbidities, unable to even walk slowly) * Inability to speak and read English.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07215091 clinical trial?
This trial is open to participants of all sexes, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07215091 currently recruiting?
Yes, NCT07215091 is actively recruiting participants. Contact the research team at pamela.ginex@stonybrookmedicine.edu for enrollment information.
Where is the NCT07215091 trial being conducted?
This trial is being conducted at Stony Brook, United States.
Who is sponsoring the NCT07215091 clinical trial?
NCT07215091 is sponsored by Stony Brook University. The trial plans to enroll 84 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.